바이오포토닉스 시장 규모, 점유율, 성장 및 세계 산업 분석 : 유형별, 용도별, 지역별 인사이트와 예측(2026-2034년)

Growth Factors of biophotonics market Market

The global biophotonics market size was valued at USD 66.15 billion in 2025 and is projected to grow from USD 70.31 billion in 2026 to USD 117.49 billion by 2034, exhibiting a CAGR of 6.63% during the forecast period. Asia Pacific dominated the global biophotonics market with a 41.79% share in 2025, supported by rising healthcare demand, strong life science research activity, and rapid adoption of advanced sensing technologies.

Biophotonics is an interdisciplinary field that combines photonics with biology and medicine. It includes technologies such as imaging systems, lasers, fiber optics, and spectrometers, which are widely used for disease diagnosis, medical research, therapy, and agricultural analytics. Increasing research investments and the growing use of biological sensors for early disease detection are expanding the long-term potential of the market.

MARKET OVERVIEW

The biophotonics industry is gaining momentum due to rising demand for non-invasive diagnostics and real-time monitoring solutions in healthcare and life sciences. Applications in oncology, neurology, cardiology, and infectious disease detection are driving the adoption of advanced photonic tools.

The COVID-19 pandemic initially restrained market growth due to limited infrastructure and lack of awareness regarding communicable disease monitoring. However, post-pandemic recovery has accelerated research activities and increased demand for portable, quick-response sensing and monitoring devices. This shift has strengthened the long-term outlook of the biophotonics market.

BIOPHOTONICS MARKET TRENDS

Integration of AI and ML in Life Sciences

The integration of Artificial Intelligence (AI) and Machine Learning (ML) is a key trend shaping the biophotonics market. AI-enabled software platforms combined with advanced photonic sensors are improving diagnostic accuracy and enabling faster disease detection.

Machine learning models trained on large biomedical datasets allow precise interpretation of imaging and spectroscopy results. The growing use of miniaturized health monitoring systems and AI-powered diagnostic tools is expected to further enhance the adoption of biophotonics technologies across healthcare and agricultural research applications.

MARKET GROWTH FACTORS

Technological Advancements and Demand for Safe Products

Rising global healthcare expenditure is driving continuous technological advancements in imaging, microscopy, and spectroscopy. The demand for non-invasive, real-time, and accurate diagnostic devices across personal and commercial healthcare settings is a major growth driver.

For instance, in January 2024, Carl Zeiss AG launched Lattice SIM 3 and Lattice SIM 5 superresolution microscopes, designed to overcome the limitations of traditional light microscopy. Such innovations are accelerating the adoption of biophotonics solutions worldwide.

RESTRAINING FACTORS

High Costs and Regulatory Challenges

High initial investment costs and complex manufacturing processes pose challenges to market growth. Biophotonic devices require strict regulatory compliance and certification, increasing capital requirements for manufacturers.

Additionally, growing competition from startups and restructuring initiatives by major players may restrict product diversification. For example, in May 2024, Hamamatsu Photonics sold its subsidiary NKT Photonics to streamline operations, reflecting restructuring trends within the industry.

MARKET SEGMENTATION ANALYSIS

By Product

Based on products, the market is segmented into imaging systems, lasers, fiber optics, and others (spectrometers). The laser segment dominated the market with a 35.87% share in 2026, driven by its extensive use in cancer treatment, light therapy, and dermatological procedures.

Imaging systems are expected to register the highest CAGR due to their increasing application in early disease detection and medical monitoring. Fiber optics and spectrometers continue to support market growth through applications in agriculture analytics and pathogen detection.

By Application

By application, the market includes biological sensing & process, live cell imaging, optical sensing & detection, photosynthesis evaluation, and others. The biological sensing & process segment held a 37.73% share in 2026, supported by rising investments in life science research.

REGIONAL INSIGHTS

Asia Pacific led the market with a valuation of USD 27.65 billion in 2025, reaching USD 29.89 billion in 2026. China is projected to reach USD 14.57 billion, Japan USD 5.99 billion, and India USD 4.29 billion by 2026, driven by healthcare and agro-IoT investments.

North America is projected to grow steadily, with the U.S. market reaching USD 4.9 billion by 2026. Europe shows stable growth, with Germany projected at USD 4.66 billion and the UK at USD 3.68 billion by 2026.

KEY INDUSTRY PLAYERS

Key players include Hamamatsu Photonics, Olympus Corporation, Zeiss, Thermo Fisher Scientific, PerkinElmer, Bio-Rad Laboratories, Shimadzu, BD, Lumenis Ltd., and Zecotek Photonics. These companies focus on R&D investments, advanced product development, and strategic launches to strengthen market positioning.

Conclusion

The global biophotonics market is expected to grow from USD 66.15 billion in 2025 to USD 117.49 billion by 2034, driven by technological advancements, AI integration, and rising demand for non-invasive diagnostic solutions. While high costs and regulatory challenges remain, increasing investments in healthcare, life science research, and agricultural analytics are supporting sustained market growth. Asia Pacific will continue to lead the market, while innovation and product development by key players will shape the future of the biophotonics industry over the forecast period.

Segmentation By Products

• Imaging Systems
• Lasers
• Fiber Optics
• Others (Spectrometer, etc.)

By Application

• Biological sensing & process
• Live Cell Imaging
• Optical sensing & detection
• Photosynthesis evaluation
• Others (intracellular cAMP, scanner, etc.)

By Region

• North America (By Product, By Application, and By Country)
  • U.S. (By Application)
  • Canada (By Application)
  • Mexico (By Application)
• Europe (By Product, By Application, and By Country)
  • U.K. (By Application)
  • Germany (By Application)
  • France (By Application)
  • Italy (By Application)
  • Spain (By Application)
  • Russia (By Application)
  • Rest of Europe
• Asia Pacific (By Product, By Application, and By Country)
  • China (By Application)
  • India (By Application)
  • Japan (By Application)
  • South Korea (By Application)
  • ASEAN (By Application)
  • Rest of Asia Pacific
• Middle East & Africa (By Product, By Application, and By Country)
  • GCC (By Application)
  • South Africa (By Application)
  • Rest of Middle East & Africa (By Application)
• South America (By Product, By Application, and By Country)
  • Brazil (By Application)
  • Argentina (By Application)
  • Rest of South America

Table of Content

1. Introduction

• 1.1. Definition, By Segment
• 1.2. Research Methodology/Approach
• 1.3. Data Sources

2. Executive Summary

3. Market Dynamics

• 3.1. Macro and Micro Economic Indicators
• 3.2. Drivers, Restraints, Opportunities and Trends
• 3.3. Impact of Generative AI

4. Competition Landscape

• 4.1. Business Strategies Adopted by Key Players
• 4.2. Consolidated SWOT Analysis of Key Players
• 4.3. Global Biophotonics Key Players Market Share/Ranking, 2025

5. Global Biophotonics Market Size Estimates and Forecasts, By Segments, 2021-2034

• 5.1. Key Findings
• 5.2. By Product (USD)
  • 5.2.1. Imaging Systems
  • 5.2.2. Lasers
  • 5.2.3. Fiber Optics
  • 5.2.4. Others (Spectrometer, etc.)
• 5.3. By Application (USD)
  • 5.3.1. Biological sensing & process
  • 5.3.2. Live Cell Imaging
  • 5.3.3. Optical sensing & detection
  • 5.3.4. Photosynthesis evaluation
  • 5.3.5. Others (intracellular cAMP, scanner, etc.)
• 5.4. By Region (USD)
  • 5.4.1. North America
  • 5.4.2. Europe
  • 5.4.3. Asia Pacific
  • 5.4.4. Middle East & Africa
  • 5.4.5. South America

6. North America Biophotonics Market Size Estimates and Forecasts, By Segments, 2021-2034

• 6.1. Key Findings
• 6.2. By Product (USD)
  • 6.2.1. Imaging Systems
  • 6.2.2. Lasers
  • 6.2.3. Fiber Optics
  • 6.2.4. Others (Spectrometer, etc.)
• 6.3. By Application (USD)
  • 6.3.1. Biological sensing & process
  • 6.3.2. Live Cell Imaging
  • 6.3.3. Optical sensing & detection
  • 6.3.4. Photosynthesis evaluation
  • 6.3.5. Others (intracellular cAMP, scanner, etc.)
• 6.4. By Country (USD)
  • 6.4.1. United States
    • 6.4.1.1. By Application
  • 6.4.2. Canada
    • 6.4.2.1. By Application
  • 6.4.3. Mexico
    • 6.4.3.1. By Application

7. South America Biophotonics Market Size Estimates and Forecasts, By Segments, 2021-2034

• 7.1. Key Findings
• 7.2. By Product (USD)
  • 7.2.1. Imaging Systems
  • 7.2.2. Lasers
  • 7.2.3. Fiber Optics
  • 7.2.4. Others (Spectrometer, etc.)
• 7.3. By Application (USD)
  • 7.3.1. Biological sensing & process
  • 7.3.2. Live Cell Imaging
  • 7.3.3. Optical sensing & detection
  • 7.3.4. Photosynthesis evaluation
  • 7.3.5. Others (intracellular cAMP, scanner, etc.)
• 7.4. By Country (USD)
  • 7.4.1. Brazil
    • 7.4.1.1. By Application
  • 7.4.2. Argentina
    • 7.4.2.1. By Application
  • 7.4.3. Rest of South America

8. Europe Biophotonics Market Size Estimates and Forecasts, By Segments, 2021-2034

• 8.1. Key Findings
• 8.2. By Product (USD)
  • 8.2.1. Imaging Systems
  • 8.2.2. Lasers
  • 8.2.3. Fiber Optics
  • 8.2.4. Others (Spectrometer, etc.)
• 8.3. By Application (USD)
  • 8.3.1. Biological sensing & process
  • 8.3.2. Live Cell Imaging
  • 8.3.3. Optical sensing & detection
  • 8.3.4. Photosynthesis evaluation
  • 8.3.5. Others (intracellular cAMP, scanner, etc.)
• 8.4. By Country (USD)
  • 8.4.1. United Kingdom
    • 8.4.1.1. By Application
  • 8.4.2. Germany
    • 8.4.2.1. By Application
  • 8.4.3. France
    • 8.4.3.1. By Application
  • 8.4.4. Italy
    • 8.4.4.1. By Application
  • 8.4.5. Spain
    • 8.4.5.1. By Application
  • 8.4.6. Russia
    • 8.4.6.1. By Application
  • 8.4.7. Rest of Europe

9. Middle East & Africa Biophotonics Market Size Estimates and Forecasts, By Segments, 2021-2034

• 9.1. Key Findings
• 9.2. By Product (USD)
  • 9.2.1. Imaging Systems
  • 9.2.2. Lasers
  • 9.2.3. Fiber Optics
  • 9.2.4. Others (Spectrometer, etc.)
• 9.3. By Application (USD)
  • 9.3.1. Biological sensing & process
  • 9.3.2. Live Cell Imaging
  • 9.3.3. Optical sensing & detection
  • 9.3.4. Photosynthesis evaluation
  • 9.3.5. Others (intracellular cAMP, scanner, etc.)
• 9.4. By Country (USD)
  • 9.4.1. GCC
    • 9.4.1.1. By Application
  • 9.4.2. South Africa
    • 9.4.2.1. By Application
  • 9.4.3. Rest of MEA

10. Asia Pacific Biophotonics Market Size Estimates and Forecasts, By Segments, 2021-2034

• 10.1. Key Findings
• 10.2. By Product (USD)
  • 10.2.1. Imaging Systems
  • 10.2.2. Lasers
  • 10.2.3. Fiber Optics
  • 10.2.4. Others (Spectrometer, etc.)
• 10.3. By Application (USD)
  • 10.3.1. Biological sensing & process
  • 10.3.2. Live Cell Imaging
  • 10.3.3. Optical sensing & detection
  • 10.3.4. Photosynthesis evaluation
  • 10.3.5. Others (intracellular cAMP, scanner, etc.)
• 10.4. By Country (USD)
  • 10.4.1. China
    • 10.4.1.1. By Application
  • 10.4.2. India
    • 10.4.2.1. By Application
  • 10.4.3. Japan
    • 10.4.3.1. By Application
  • 10.4.4. South Korea
    • 10.4.4.1. By Application
  • 10.4.5. ASEAN
    • 10.4.5.1. By Application
  • 10.4.6. Rest of Asia Pacific

11. Company Profiles for Top 10 Players (Based on data availability in public domain and/or on paid databases)

• 11.1. Hamamatsu Photonics
  • 11.1.1. Overview
    • 11.1.1.1. Key Management
    • 11.1.1.2. Headquarters
    • 11.1.1.3. Offerings/Business Segments
  • 11.1.2. Key Details (Key details are consolidated data and not product/service specific)
    • 11.1.2.1. Employee Size
    • 11.1.2.2. Past and Current Revenue
    • 11.1.2.3. Geographical Share
    • 11.1.2.4. Business Segment Share
    • 11.1.2.5. Recent Developments
• 11.2. Olympus Corporation
  • 11.2.1. Overview
    • 11.2.1.1. Key Management
    • 11.2.1.2. Headquarters
    • 11.2.1.3. Offerings/Business Segments
  • 11.2.2. Key Details (Key details are consolidated data and not product/service specific)
    • 11.2.2.1. Employee Size
    • 11.2.2.2. Past and Current Revenue
    • 11.2.2.3. Geographical Share
    • 11.2.2.4. Business Segment Share
    • 11.2.2.5. Recent Developments
• 11.3. Affymetrix (thermo fisher scientific)
  • 11.3.1. Overview
    • 11.3.1.1. Key Management
    • 11.3.1.2. Headquarters
    • 11.3.1.3. Offerings/Business Segments
  • 11.3.2. Key Details (Key details are consolidated data and not product/service specific)
    • 11.3.2.1. Employee Size
    • 11.3.2.2. Past and Current Revenue
    • 11.3.2.3. Geographical Share
    • 11.3.2.4. Business Segment Share
    • 11.3.2.5. Recent Developments
• 11.4. Zeiss
  • 11.4.1. Overview
    • 11.4.1.1. Key Management
    • 11.4.1.2. Headquarters
    • 11.4.1.3. Offerings/Business Segments
  • 11.4.2. Key Details (Key details are consolidated data and not product/service specific)
    • 11.4.2.1. Employee Size
    • 11.4.2.2. Past and Current Revenue
    • 11.4.2.3. Geographical Share
    • 11.4.2.4. Business Segment Share
    • 11.4.2.5. Recent Developments
• 11.5. Zecotek Photonics Inc
  • 11.5.1. Overview
    • 11.5.1.1. Key Management
    • 11.5.1.2. Headquarters
    • 11.5.1.3. Offerings/Business Segments
  • 11.5.2. Key Details (Key details are consolidated data and not product/service specific)
    • 11.5.2.1. Employee Size
    • 11.5.2.2. Past and Current Revenue
    • 11.5.2.3. Geographical Share
    • 11.5.2.4. Business Segment Share
    • 11.5.2.5. Recent Developments
• 11.6. BD (Becton, Dickinson, and Company)
  • 11.6.1. Overview
    • 11.6.1.1. Key Management
    • 11.6.1.2. Headquarters
    • 11.6.1.3. Offerings/Business Segments
  • 11.6.2. Key Details (Key details are consolidated data and not product/service specific)
    • 11.6.2.1. Employee Size
    • 11.6.2.2. Past and Current Revenue
    • 11.6.2.3. Geographical Share
    • 11.6.2.4. Business Segment Share
    • 11.6.2.5. Recent Developments
• 11.7. PerkinElmer Inc.
  • 11.7.1. Overview
    • 11.7.1.1. Key Management
    • 11.7.1.2. Headquarters
    • 11.7.1.3. Offerings/Business Segments
  • 11.7.2. Key Details (Key details are consolidated data and not product/service specific)
    • 11.7.2.1. Employee Size
    • 11.7.2.2. Past and Current Revenue
    • 11.7.2.3. Geographical Share
    • 11.7.2.4. Business Segment Share
    • 11.7.2.5. Recent Developments
• 11.8. Lumenis Ltd.
  • 11.8.1. Overview
    • 11.8.1.1. Key Management
    • 11.8.1.2. Headquarters
    • 11.8.1.3. Offerings/Business Segments
  • 11.8.2. Key Details (Key details are consolidated data and not product/service specific)
    • 11.8.2.1. Employee Size
    • 11.8.2.2. Past and Current Revenue
    • 11.8.2.3. Geographical Share
    • 11.8.2.4. Business Segment Share
    • 11.8.2.5. Recent Developments
• 11.9. Bio-Rad Laboratories, Inc.
  • 11.9.1. Overview
    • 11.9.1.1. Key Management
    • 11.9.1.2. Headquarters
    • 11.9.1.3. Offerings/Business Segments
  • 11.9.2. Key Details (Key details are consolidated data and not product/service specific)
    • 11.9.2.1. Employee Size
    • 11.9.2.2. Past and Current Revenue
    • 11.9.2.3. Geographical Share
    • 11.9.2.4. Business Segment Share
    • 11.9.2.5. Recent Developments
• 11.10. Shimadzu
  • 11.10.1. Overview
    • 11.10.1.1. Key Management
    • 11.10.1.2. Headquarters
    • 11.10.1.3. Offerings/Business Segments
  • 11.10.2. Key Details (Key details are consolidated data and not product/service specific)
    • 11.10.2.1. Employee Size
    • 11.10.2.2. Past and Current Revenue
    • 11.10.2.3. Geographical Share
    • 11.10.2.4. Business Segment Share
    • 11.10.2.5. Recent Developments

12. Key Takeaways